TrialVascular health and risk management2018

Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study).

Shosaku Nomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.